Harvard Medical School and ORGANOPlus Join Forces to Advance Next-Generation IBD Organoid Chip Models

ORGANOPlus signed an MOU with Harvard Medical School to co-develop intestinal muscle–integrated IBD organoid chip models. The partnership combines Harvard’s bio-printed muscle expertise with ORGANOPlus’s VILLIORGAN™ platform to enhance disease relevance and enable precise validation of new IBD therapeutics.